Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Taking Propecia might lead to the development of cataracts.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Hair restoration has evolved from surgery to drugs to potential gene therapy, with improved results and ongoing research driven by high demand.

Bioprinting could greatly improve health outcomes but faces challenges like material choice and ensuring long-term survival of printed tissues.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Finasteride, often used for hair loss, can potentially cause cataracts.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Targeting colon cancer stem cells might lead to better treatment results.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Hirsutism causes significant psychological distress in women.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

A group has developed therapies that show promise for treating cancer and various other conditions.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.

Activating Notch signaling can kill basal cell carcinoma cells.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.